Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Zipp

Showing results (291-300 of 317) with videos related to

Pageof 32
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 15, 2025
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G SynthesisAlbert Pukaj, Adil Harroud, Klementy Shchetynsky, et al.
Clinical Chemistry and Laboratory Medicine|September 13, 2023
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injuryDavid Wilson, Dandan Chan, Lei Chang, et al.
The Journal of Experimental Medicine|July 30, 2008
Autoregulation of Th1-mediated inflammation by twist1Uwe Niesner, Inka Albrecht, Marko Janke, et al.
Journal of Medical Genetics|January 15, 2013
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis riskChristina M Lill, Brit-Maren M Schjeide, Christiane Graetz, et al.
Science Translational Medicine|March 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectoriesCatharina C Gross, Andreas Schulte-Mecklenbeck, Olga V Steinberg, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Pageof 32

Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 15, 2025
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G SynthesisAlbert Pukaj, Adil Harroud, Klementy Shchetynsky, et al.
Clinical Chemistry and Laboratory Medicine|September 13, 2023
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injuryDavid Wilson, Dandan Chan, Lei Chang, et al.
The Journal of Experimental Medicine|July 30, 2008
Autoregulation of Th1-mediated inflammation by twist1Uwe Niesner, Inka Albrecht, Marko Janke, et al.
Journal of Medical Genetics|January 15, 2013
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis riskChristina M Lill, Brit-Maren M Schjeide, Christiane Graetz, et al.
Science Translational Medicine|March 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectoriesCatharina C Gross, Andreas Schulte-Mecklenbeck, Olga V Steinberg, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Pageof 32